| Endothelial cell infection and dysfunction, immune activation in severe COVID-19 Z Qin, F Liu, R Blair, C Wang, H Yang, J Mudd, JM Currey, N Iwanaga, ... Theranostics 11 (16), 8076, 2021 | 90 | 2021 |
| Micro RNA‐mediated regulation of T helper type 17/regulatory T‐cell balance in autoimmune disease C Liu, H Yang, W Shi, T Wang, Q Ruan Immunology 155 (4), 427-434, 2018 | 59 | 2018 |
| Vaccine-driven lung TRM cells provide immunity against Klebsiella via fibroblast IL-17R signaling N Iwanaga, K Chen, H Yang, S Lu, JP Hoffmann, A Wanek, JE McCombs, ... Science immunology 6 (63), eabf1198, 2021 | 33 | 2021 |
| MicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake R Liu, C Liu, X He, P Sun, B Zhang, H Yang, W Shi, Q Ruan Nature communications 13 (1), 3545, 2022 | 19 | 2022 |
| ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2 N Iwanaga, L Cooper, L Rong, NJ Maness, B Beddingfield, Z Qin, ... Iscience 25 (1), 2022 | 18 | 2022 |
| Hematopoietic and lung platelet biogenesis as a prognostic indicator in idiopathic pulmonary fibrosis S Saito, CHH Chung, A Jacob, N Nuradin, AE Meyer, H Yang, JK Kolls, ... American journal of respiratory and critical care medicine 206 (9), 1174-1177, 2022 | 4 | 2022 |
| Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in Rag2−/− Mice CR Ellsworth, C Wang, AR Katz, Z Chen, M Islamuddin, H Yang, ... Viruses 16 (4), 611, 2024 | | 2024 |
| Vaccine-elicited IL-1R signaling results in Th17 TRM-mediated immunity JP Hoffmann, A Srivastava, H Yang, N Iwanaga, TP Remcho, JL Hewes, ... Communications Biology 7 (1), 433, 2024 | | 2024 |
| Embigin Is Highly Expressed on CD4+ and CD8+ T Cells but Is Dispensable for Several T Cell Effector Responses H Yang, N Iwanaga, AR Katz, AR Ridley, HD Miller, MJ Allen, D Pociask, ... ImmunoHorizons 8 (3), 242-253, 2024 | | 2024 |
| Vaccine Mediated Lung Tissue Resident Memory T Cells Require IL-1 and CCR2 Signaling to Protect Against K. Pneumoniae Challenge JP Hoffmann, N Iwanaga, H Yang, EB Norton, JE Mccombs, JK Kolls A101. DEFINING CELLULAR AND MOLECULAR IMMUNE MECHANISMS IN LUNG INFECTIONS …, 2022 | | 2022 |
| Single-Cell RNA-seq Revealed T Cell Metabolism as a Target to Tissue-Resident Memory T Cell Contraction H Yang, JK Kolls B31. IMMUNE CELLS AND INFLAMMATORY PATHWAYS DRIVING LUNG INJURY AND …, 2022 | | 2022 |
| A Novel Immunotherapy with Adoptive Transfer of Immunized CD4 T-Cells Against Klebsiella Pneumoniae N Iwanaga, H Yang, K Chen, E Norton, J Moreno, JK Kolls, JE Mccombs TP2. TP002 IMMUNOLOGY AND INFLAMMATION IN PULMONARY INFECTIONS, A1251-A1251, 2021 | | 2021 |
| Mucosal LTA1 Elicits Lung Th17 cells with reduced plasticity towards Th1 cells and resistance to FK506. H Yang, N Iwanaga, EB Norton, JK Kolls The Journal of Immunology 206 (1_Supplement), 17.19-17.19, 2021 | | 2021 |
| Genetically engineered CD4 T cells as a novel immunotherapy against drug resistant Klebsiella pneumoniae infections. JP Hoffmann, N Iwanaga, H Yang, K Chen, EB Norton, J Rangel-Moreno, ... The Journal of Immunology 206 (1_Supplement), 59.12-59.12, 2021 | | 2021 |
Jay KollsProfessor of Medicine and Pediatrics, Tulane School of MedicineVerified email at tulane.edu
